NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs LY 3023414 (Primary)
- Indications CNS cancer; Ependymoma; Germ cell and embryonal neoplasms; Glioma; Langerhans cell histiocytosis; Medulloblastoma; Neuroblastoma; Non-Hodgkin's lymphoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Solid tumours; Wilms' tumour
- Focus Therapeutic Use
- Acronyms Pediatric MATCH
- 04 Aug 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2017 Planned initiation date changed from 24 Jul 2017 to 16 Sep 2017.
- 13 Jul 2017 New trial record